Eli Lilly to boost manufacturing and supply in India with $1bn investment

The company launched its blockbuster weight-loss drug Mounjaro in India this year

Eli Lilly launched its blockbuster weight-loss drug Mounjaro in India this year. Picture:: Niall Carson/PA Wire

Eli Lilly will invest more than $1bn (€850m) in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, as it seeks to tap into skilled workforce to bolster its global manufacturing expansion.

The collaborations aim to increase the availability of Lilly's key drugs, including those for obesity, diabetes, Alzheimer's, cancer and autoimmune conditions, the company said.